Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Treatment for Symptomatic Peripheral Neuropathy in Patients With Diabetes
This study has been completed.
Study NCT00044395 Information provided by Eli Lilly and Company
First Received on August 28, 2002. Last Updated on November 5, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Neuropathies
Additional conditions recognized in this trial
Demyelinating Diseases
Diabetes Mellitus
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Nerve Compression Syndromes
Neurologic Manifestations
Neurotoxicity Syndromes
Peripheral Nervous System Diseases
Polyneuropathies
More general conditions related to this trial
Autoimmune Diseases
Diabetes Complications
Endocrine System Diseases
Glucose Metabolism Disorders
Immune System Diseases
Metabolic Diseases
Nervous System Diseases
Neuromuscular Diseases
Poisoning
Signs and Symptoms
Substance-Related Disorders
Interventions listed in this trial
Ruboxistaurin mesylate
Additional drug interventions recognized in this trial
Ruboxistaurin
More general drug interventions related to this trial
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Sponsors listed in this trial
Eli Lilly and Company
Back to top of Main Content
